The Dodgers’ ability to put off long-term payments while reaping short-term benefits is raising new fears about a competitive ...

Keros Therapeutics (NASDAQ:KROS – Free Report) had its price target lowered by Piper Sandler from $40.00 to $15.00 in a research report report published on Friday,Benzinga reports. The firm currently ...

With groundbreaking biennials, major exhibitions and highly anticipated museum debuts, 2025 promises an exciting year of art ...

Juan Ignacio Vidarte have revealed the keys to the eleven exhibitions that visitors will be able to enjoy in 2025.